Multicenterstudie zur Validierung der Klassifikation 1.1 für Frakturen langer Röhrenknochen im Wachstumsalter

Fragestellung Zur Qualitätsbeurteilung von Diagnose und Therapie kindlicher Frakturen bedarf es einer Frakturklassifikation, die Aufwand und Ergebnisse vergleichbar macht und die Besonderheiten kindlicher Frakturen berücksichtigt. Die für den Erwachsenen gebräuchliche AO-Klassifikation kann danach nicht auf kindliche Frakturen übertragen werden. Eine im Jahr 2000 bereits vorgelegte Klassifikation (Eur. J. Trauma 2000) wurde überarbeitet und in der sechsdimensionalen Version 1.1 in einer multizentischen Studie validiert. Hierbei erfolgte eine Unterscheidung der langen Röhrenknochen, der Lokalisation am Knochen, eine Bestimmung der paarigen Knochen sowie des Frakturverlaufs im Bereich der Epiphyse, Metaphyse und Diaphyse. Die supracondylären Humerusfrakturen wurden gesondert klassifiziert. Methoden 13 Kliniken (D, CH, A) erfassten in 3 Monaten 720 Frakturen und 452 Kontrollen nach bis zu 9 Monaten mit standardisierten Fragebögen sowie 1480 digitalisierte Röntgenbilder. Aus diesem Datenpool wurde nach Vorevaluation der relevantesten Frakturtypen durch 7 verblindete Untersucher und Varianzanalyse die finale Gruppe von 150 Fällen des gesamten Frakturspektrums klassifiziert. Statistisch untersucht wurde die Wiederholbarkeitsanalyse über Zeit (Test-Retest) und die Interobservervariabilität. Ergebnisse Korrelationen (r) zwischen 0.99 und 0.91 ergaben sich für die Dimensionen 1 (Ober-/Unterarm, Ober-/Unterschenkel), 2 (distal, zentral, proximal) und 4 (Ulna, Radius, Tibia, Fibula), von 0.74 für Dimension 6 (Subtypisierung der Dislokation bei supracond. Frakturen), 0.66 für Dimension 5 (Subtypisierung des Frakturverlaufs) und 0.33 für Dimension 3 (Epiphyse, Metaphyse, Diaphyse). Bei der Wiederholung stimmten für die Gesamtgruppe in 18% der Fälle alle sechs Dimensionen überein, in 71% fünf und in 88% vier Dimensionen der Klassifikation. Schlussfolgerungen Insgesamt stellt die vorgestellte Klassifikation ein sinnvolles Instrument in der Frakturbehandlung von Kindern dar, indem es eine klare Fraktureinteilung im Kindesalter erlaubt. Die Evaluation zeigt jedoch auch die Schwierigkeiten einer Frakturklassifikation in speziellen Untergruppen auf. Da diese hinsichtlich der Therapie keine Relevanz haben, ist eine weitere Vereinfachung möglich. Meeting Abstract (DGU 2004) am 68. Jahrestagung der Deutschen Gesellschaft für Unfallchirurgie ; 90. Tagung der Deutschen Gesellschaft für Orthopädie und Orthopädische Chirurgie ; 45. Tagung des Berufsverbandes der Fachärzte für Orthopädie in Zusammenarbeit mit dem Deutschen Verband für Physiotherapie – Zentralverband der Physiotherapeuten/Krankengymnasten ; 19. bis 23.10.2004, Berli

Do immaturity, dehydratation or alkalosis predispose to intraoperative complications at pyloromyotomy?

$\textbf {Background:}$ Hypertrophic pyloric stenosis is the most important cause for propulsive non-bilious vomiting in infants of the first trimester. Extramucous splitting of the hypertrophic pyloric muscle is the surgical gold standard for treatment. Serious major complications of pyloromyotomy (PM) are mucosal perforation and incomplete muscle splitting. The aim of the presented study is to find out if intraoperative complications are predisposed by biometric or biochemical factors. Furthermore, we looked for the influence of the board certification of the primary surgeon. $\textbf {Patients and Methods:}$ 162 infants with IHPS were operated during a six-year period ($\it n$ = 150 laparoscopic operations). We had 8 major complications (4.9%): iatrogenic mucosal perforation occurred in 6 cases, and incomplete PM in 2 infants. Preoperative demographic data and data resulting from the blood acid-base- and ion-analysis were compared with data of a previously published reference group from our institution (Tröbs RB. Open J Pediatr, 2014; 4: 208-215). $\textbf {Results:}$ The duration of vomiting, the grade of dehydration and the severity of blood alkalosis did not differ between both groups. Furthermore, we found no influence of the gestational age and birth weight on the occurrence of intraoperative complications. It seems that early postnatal age (p = 0.07) and low body weight at surgery (p = 0.055) may contribute to surgical problems. Board certification as a paediatric surgeon did not influence the rate of intraoperative complications. $\textbf {Conclusions:}$ Laboratory data did not show any predisposition to intraoperative complications. It is assumed that small infants with early occurring symptoms carry an elevated risk for intraoperative events. Our data support the hypothesis that the rate of intraoperative complications at PM is mainly influenced by skills and experience of the surgeon

“Inverse type” apple-peel syndrome is associated with type III colonic atresia in a neonate with gastroschisis

The colon is an unusual site of intestinal atresia. Colonic atresia is subdivided into three phenotypes. Type III is the most common phenotype, where the proximal and distal blind sacs are not connected. Here, we report on the presence of colonic atresia with an “inverse apple-peel” appearance in a neonate with gastroschisis. The lack of mesenteric fixation of the entire small intestine, including the proximal colon, and the twisting around the vascular axis of the superior mesenteric artery led to intrauterine volvulus and hemorrhagic infarction of the ileocolic bowel at 34 weeks of gestation. According to the current nomenclature for small bowel atresia, we introduce type IIIB into the current colonic atresia classification. The occurrence of type IIIB has been mentioned in the literature, but no single cases have been reported until now. Patients with this type of atresia are predisposed to the loss of the ileocecal region

Guidelines for the use and interpretation of assays for monitoring autophagy

In 2008 we published the first set of guidelines for standardizing research in autophagy. Since then, research on this topic has continued to accelerate, and many new scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Accordingly, it is important to update these guidelines for monitoring autophagy in different organisms. Various reviews have described the range of assays that have been used for this purpose. Nevertheless, there continues to be confusion regarding acceptable methods to measure autophagy, especially in multicellular eukaryotes. A key point that needs to be emphasized is that there is a difference between measurements that monitor the numbers or volume of autophagic elements (e.g., autophagosomes or autolysosomes) at any stage of the autophagic process vs. those that measure flux through the autophagy pathway (i.e., the complete process); thus, a block in macroautophagy that results in autophagosome accumulation needs to be differentiated from stimuli that result in increased autophagic activity, defined as increased autophagy induction coupled with increased delivery to, and degradation within, lysosomes (in most higher eukaryotes and some protists such as Dictyostelium) or the vacuole (in plants and fungi). In other words, it is especially important that investigators new to the field understand that the appearance of more autophagosomes does not necessarily equate with more autophagy. In fact, in many cases, autophagosomes accumulate because of a block in trafficking to lysosomes without a concomitant change in autophagosome biogenesis, whereas an increase in autolysosomes may reflect a reduction in degradative activity. Here, we present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes. These guidelines are not meant to be a formulaic set of rules, because the appropriate assays depend in part on the question being asked and the system being used. In addition, we emphasize that no individual assay is guaranteed to be the most appropriate one in every situation, and we strongly recommend the use of multiple assays to monitor autophagy. In these guidelines, we consider these various methods of assessing autophagy and what information can, or cannot, be obtained from them. Finally, by discussing the merits and limits of particular autophagy assays, we hope to encourage technical innovation in the field